Testing an aetiological model of visual hallucinations in Parkinson's disease DA Gallagher, L Parkkinen, SS O'Sullivan, A Spratt, A Shah, CC Davey, ... Brain 134 (11), 3299-3309, 2011 | 169 | 2011 |
The relationship between diurnal variations in intraocular pressure measurements and central corneal thickness and corneal hysteresis A Kotecha, DP Crabb, A Spratt, DF Garway-Heath Investigative ophthalmology & visual science 50 (9), 4229-4236, 2009 | 95 | 2009 |
Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series A Kotecha, A Spratt, L Ogunbowale, R dell’Omo, A Kulkarni, C Bunce, ... Archives of Ophthalmology 129 (2), 145-150, 2011 | 61 | 2011 |
Optic disc and visual field changes after trabeculectomy A Kotecha, A Spratt, C Bunce, DF Garway-Heath, PT Khaw, ... Investigative ophthalmology & visual science 50 (10), 4693-4699, 2009 | 57 | 2009 |
Visual function and fitness to drive A Kotecha, A Spratt, A Viswanathan British medical bulletin 87 (1), 163-174, 2008 | 56 | 2008 |
Chronic anterior uveitis following bacille Calmette–Guérin vaccination: molecular mimicry in action? A Spratt, T Key, AJ Vivian Journal of Pediatric Ophthalmology & Strabismus 45 (4), 252-253, 2008 | 53 | 2008 |
Quality of life in glaucoma A Spratt, A Kotecha, A Viswanathan Journal of Current Glaucoma Practice 2 (1), 39-45, 2008 | 23 | 2008 |
Predicting visual field loss in ocular hypertensive patients using wavelet-fourier analysis of GDx scanning laser polarimetry EA Essock, P Gunvant, Y Zheng, DF Garway-Heath, A Kotecha, A Spratt Optometry and Vision Science 84 (5), E380-E387, 2007 | 21 | 2007 |
Longitudinal change in central corneal thickness in the Tema Eye Survey JC Mwanza, SE Tulenko, DL Budenz, E Mathenge, LH Herndon, HY Kim, ... American Journal of Ophthalmology 186, 10-18, 2018 | 15 | 2018 |
What's in a name? New glaucoma drugs A Spratt, L Ogunbowale, R Wormald, W Franks The Lancet 368 (9538), 826-827, 2006 | 7 | 2006 |
Anesthesia: 2-Volume Set RD Miller, LI Eriksson, L Fleisher, JP Wiener-Kronish, WL Young Elsevier Health Sciences, 2013 | 5 | 2013 |
Drops and falls A Spratt, L Ogunbowale, A Khawaja, W Franks Age and ageing 35 (6), 646-646, 2006 | 5 | 2006 |
Bevacizumab: a compassionate way of doing business? A Spratt, L Ogunbowale, W Franks Eye 21 (6), 890-891, 2007 | 4 | 2007 |
Treatment of recalcitrant cyclitic neovascular pupillary membranes A Spratt, LS Blieden, SR Dubovy, A Berrocal, RK Lee Journal of glaucoma 26 (4), e160-e162, 2017 | 2 | 2017 |
Clear lens extraction for angle closure A Spratt, MN Welch, RK Parrish Ophthalmology 120 (10), e71, 2013 | 2 | 2013 |
Patient reported outcomes in glaucoma: associations between the NEI VFQ-25 and the GQL-15 and clinical measures of visual function S Pourjavan, A Spratt, A Kotecha Investigative Ophthalmology & Visual Science 51 (13), 187-187, 2010 | 2 | 2010 |
Central retinal vein occlusion heralding the relapse of haematodermic neoplasm J Tee, A Spratt, K Cwynarski, C Davey British journal of haematology 143 (3), 305-305, 2008 | 2 | 2008 |
Incidence of glaucoma progression and rate of visual field deterioration in a cohort of urban Ghanaians JC Mwanza, SE Tulenko, DL Budenz, LW Herndon, A Hall, G Hay-Smith, ... Journal of Glaucoma 31 (7), 503-510, 2022 | 1 | 2022 |
Do subjective and objective indices of disease severity correlate with perceived disability in new glaucoma referrals? A Bach, L Ogunbowlae, A Kotecha, A Spratt Austin Journal of Clinical Ophthalmology, 2015 | 1 | 2015 |
Ophthalmic pathology and visual hallucinations (VH) in PD D Gallagher, A Spratt, A Shah, F Bremmer, C Davey, A Lees, A Schrag MOVEMENT DISORDERS 25 (7), S280-S280, 2010 | 1 | 2010 |